T. Rowe Price Concentrated Global Eq S
ETL0923AU
T. Rowe Price Concentrated Global Eq S ETL0923AU Strategy
The fund's strategy applies an active, core style approach to a global opportunity set to create a portfolio of high conviction investments in companies with competitive advantages positioned on the right side of secular change. Our research driven advantage integrates bottom-up fundamental research and absolute and relative risk measures with an aim to provide strong performance over a full market cycle.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
Funds News & Analysis
funds
Listed Investment Companies monthly performance: June 2025
The Morningstar LIC monthly report provides a snapshot of ASX-listed LICs, and whether they are trading at a premium or a discount to their net tangible assets (NTA).
funds
Listed Investment Companies monthly performance: May 2025
The Morningstar LIC monthly report provides a snapshot of ASX-listed LICs, and whether they are trading at a premium or a discount to their net tangible assets (NTA).
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,963.50 | 29.20 | 0.33% |
CAC 40 | 7,806.13 | 28.45 | -0.36% |
DAX 40 | 23,988.39 | 229.11 | -0.95% |
Dow JONES (US) | 44,895.12 | 6.80 | -0.02% |
FTSE 100 | 9,071.01 | 49.30 | -0.54% |
HKSE | 25,562.13 | 173.78 | 0.68% |
NASDAQ | 21,175.03 | 66.72 | 0.32% |
Nikkei 225 | 40,998.27 | 457.96 | -1.10% |
NZX 50 Index | 12,910.74 | 57.28 | 0.45% |
S&P 500 | 6,394.11 | 5.47 | 0.09% |
S&P/ASX 200 | 8,697.70 | 30.80 | 0.36% |
SSE Composite Index | 3,597.94 | 4.28 | 0.12% |